Leadership Overview
Cytiva has 4 executives leading key functions including financial strategy, information technology, genomic medicine innovation, and overall corporate operations.
Focused on accelerating the development of life-saving therapeutics, Cytiva maintains a commitment to advancing medical application technologies through global operational excellence and scientific rigor.
Focused on accelerating the development of life-saving therapeutics, Cytiva maintains a commitment to advancing medical application technologies through global operational excellence and scientific rigor.
Leadership Roles at Cytiva
Brittany Hissey - Chief Financial Officer, Hardware Solutions
Brittany Hissey, the Chief Financial Officer, Hardware Solutions at Cytiva, manages the fiscal health of the hardware manufacturing division. Hissey directs capital allocation strategies to support the production of medical application technologies. By overseeing financial planning and analysis, the Chief Financial Officer, Hardware Solutions ensures that resource distribution aligns with the broader goal of accelerating therapeutic development. Brittany Hissey monitors global market trends to optimize cost structures across North American and European manufacturing sites. This leadership role involves rigorous oversight of hardware-related investments, ensuring long-term profitability and operational efficiency. Through precise financial modeling, the Chief Financial Officer, Hardware Solutions mitigates risks associated with supply chain volatility. Hissey maintains close collaboration with the executive team to drive sustainable growth. Ultimately, the Chief Financial Officer, Hardware Solutions secures the necessary funding to maintain the competitive edge of the hardware portfolio in the global life sciences market.
Allen Li - President
Allen Li, the President at Cytiva, oversees the comprehensive strategic direction and operational execution of the global organization. Li drives the company's mission to provide essential medical application technologies that accelerate therapeutic development. By coordinating the efforts of the executive leadership team, the President ensures alignment between regional operations and corporate objectives. Allen Li manages the expansion of market presence across diverse international territories, focusing on high-growth sectors within the life sciences industry. This leadership role involves setting the long-term vision for product development and service delivery. Through active engagement with the Board, the President maintains a focus on sustainable growth and operational excellence. Li monitors the competitive landscape to identify opportunities for strategic partnerships and acquisitions. Ultimately, the President provides the overarching guidance required to maintain the company's status as a global leader in medical technology, ensuring that all divisions contribute effectively to the advancement of global health outcomes.
Steve Eichorn - Vice President, Information Technology & Chief Information Officer
Steve Eichorn, the Vice President, Information Technology & Chief Information Officer at Cytiva, architects the digital infrastructure supporting global medical technology operations. Eichorn drives the implementation of secure data systems that facilitate the rapid development of therapeutics. Overseeing the enterprise-wide digital transformation, the Vice President, Information Technology & Chief Information Officer ensures seamless connectivity across international research facilities. Steve Eichorn manages cybersecurity protocols to protect proprietary research data from global threats. This leadership role involves integrating advanced analytics into the manufacturing workflow to enhance production efficiency. By modernizing legacy systems, the Vice President, Information Technology & Chief Information Officer enables real-time collaboration between cross-functional teams. Eichorn aligns technological investments with the overarching mission of accelerating medical breakthroughs. Ultimately, the Vice President, Information Technology & Chief Information Officer maintains the robust digital backbone required for the company to scale operations effectively within the competitive life sciences landscape.
Aaron Dulgar-Tulloch - Chief Technology Officer, Genomic Medicine
Aaron Dulgar-Tulloch, the Chief Technology Officer, Genomic Medicine at Cytiva, directs the research and development initiatives focused on next-generation therapeutic platforms. Dulgar-Tulloch architects innovative solutions that accelerate the transition from laboratory research to clinical application. Overseeing the genomic medicine portfolio, the Chief Technology Officer, Genomic Medicine ensures that technical advancements meet the highest standards of medical efficacy. Aaron Dulgar-Tulloch collaborates with global scientific partners to integrate cutting-edge biotechnology into the company's service offerings. This leadership role involves managing complex R&D pipelines to address the evolving needs of the pharmaceutical industry. By fostering a culture of technical excellence, the Chief Technology Officer, Genomic Medicine drives the creation of scalable tools for genomic research. Dulgar-Tulloch monitors emerging trends in biotechnology to maintain the company's position at the forefront of medical innovation. Ultimately, the Chief Technology Officer, Genomic Medicine delivers the technical breakthroughs necessary to advance the global development of life-saving therapeutics.
Explore Leadership Teams in Manufacturing
Founded in 1989 and headquartered in Princeton, New Jersey, Integra LifeSciences is a medical technology company that develops and manufactures surgical instruments, neurosurgical devices, and advanced wound care and tissue repair products. Through its Codman Specialty Surgical and Tissue Technologies segments, the company serves neurosurgeons, neurocritical care teams, ENT specialists, plastic and reconstructive surgeons, and general surgeons. Its portfolio includes neurosurgical tools and systems such as dural repair products, cerebrospinal fluid management devices, intracranial monitoring equipment, and cranial stabilization devices, as well as surgical headlamps and general surgical instruments. Integra also provides specialized solutions for acute and chronic wound management, including burns and diabetic foot ulcers, and offers products for soft tissue, bone, nerve, and tendon repair. In ear, nose, and throat care, the company supplies instrumentation, balloon technologies for sinus and eustachian tube dilation, and surgical navigation systems. Sold through direct sales teams and distribution partners to hospitals, surgery centers, and healthcare providers worldwide, Integra LifeSciences positions itself as a comprehensive partner for complex surgical and reconstructive care.
Company Leadership SE
CV
Protective Industrial Products, Inc., headquartered in Latham, New York, is a provider of personal protective equipment (PPE) with a focus on hand protection. For over 40 years, the company has developed safety products including cut-resistant, chemical-resistant, and disposable gloves, as well as eye, head, hearing, and fall protection. It serves industrial workers and construction professionals across markets such as automotive, metal fabrication, food processing, and oil and gas. The company delivers its products through industrial, retail, and export channels, and has expanded its portfolio by acquiring the business and brand portfolio of Honeywell Safety Products.
Company Leadership
RM
Founded in 1990, Getinge is a Sweden-based company active in the healthcare sector. It provides products and services for intensive care units, sterilization centers, elderly care and companies and institutions active in the life sciences area.
Company Leadership SM
CH
EH
CC
As per the "buy and build" strategy, the next acquisition was Legacy Medical (July 2018), followed by Haemotec (Nov 2019) and LTE Medical Supplies (Feb 2019). In April 2019, the company started an Ophthalmology business (EyeCare) and have expanded the company's product range and agencies in the existing verticals. The second half of 2019 saw further acquisitions with Paragmed in November and Jumla Medical Supplies and Stratmed joining the group in December. The company is a scaled and diversified group of specialised medical service providers committed to bringing new, first-rate technologies to a wide spectrum of medical practitioners. The company provides the latest devices, software, processes and procedures that facilitate high care and quality treatment for all patients. The company's clients and partners continually receive extensive training and comprehensive technical support as the company strives towards better products, better services and more personalised customer experiences. Depiction of Vertice MedTech
Company Leadership HP
GS
EM
BM
Frequently Asked Questions Regarding Cytiva Top Executives and Leadership Team
